MAP2K5
Dual specificity mitogen-activated protein kinase kinase 5
Also known as: HsT17454, MAPKK5, MEK5, MP2K5_HUMAN, PRKMK5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13163
- Gene
- MAP2K5
- Ensembl
- ENSG00000137764
- Chromosome
- 15
- Canonical length
- 448 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoli,Microtubules,Cytokinetic bridge,Primary cilium,Basal body
OverviewNCBI Gene
The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase specifically interacts with and activates MAPK7/ERK5. This kinase itself can be phosphorylated and activated by MAP3K3/MEKK3, as well as by atypical protein kinase C isoforms (aPKCs). The signal cascade mediated by this kinase is involved in growth factor stimulated cell proliferation and muscle cell differentiation. Three alternatively spliced transcript variants of this gene encoding distinct isoforms have been described. [provided by RefSeq, May 2011]
Canonical amino-acid sequenceUniProt
448 residues, UniProt reviewed canonical sequence.
>Q13163|MAP2K5
1 MLWLALGPFP AMENQVLVIR IKIPNSGAVD WTVHSGPQLL FRDVLDVIGQ VLPEATTTAF
61 EYEDEDGDRI TVRSDEEMKA MLSYYYSTVM EQQVNGQLIE PLQIFPRACK PPGERNIHGL
121 KVNTRAGPSQ HSSPAVSDSL PSNSLKKSSA ELKKILANGQ MNEQDIRYRD TLGHGNGGTV
181 YKAYHVPSGK ILAVKVILLD ITLELQKQIM SELEILYKCD SSYIIGFYGA FFVENRISIC
241 TEFMDGGSLD VYRKMPEHVL GRIAVAVVKG LTYLWSLKIL HRDVKPSNML VNTRGQVKLC
301 DFGVSTQLVN SIAKTYVGTN AYMAPERISG EQYGIHSDVW SLGISFMELA LGRFPYPQIQ
361 KNQGSLMPLQ LLQCIVDEDS PVLPVGEFSE PFVHFITQCM RKQPKERPAP EELMGHPFIV
421 QFNDGNAAVV SMWVCRALEE RRSQQGPPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAP2K5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 22 nTPM
- parathyroid gland: 18 nTPM
- tongue: 17 nTPM
- thymus: 16 nTPM
- ovary: 16 nTPM
- colon: 15 nTPM
Single-cell type
- sertoli cells: 378 nCPM
- myonuclei: 343 nCPM
- late spermatids: 330 nCPM
- adrenal cortex cells: 277 nCPM
- gonadotrophs: 242 nCPM
- brain excitatory neurons: 223 nCPM
Immune cell
- basophil: 11 nTPM
- NK-cell: 9.5 nTPM
- MAIT T-cell: 8.4 nTPM
- myeloid DC: 8.1 nTPM
- naive CD4 T-cell: 7.3 nTPM
- naive CD8 T-cell: 7 nTPM
Brain region
- cerebral cortex: 49 nTPM
- white matter: 43 nTPM
- cerebellum: 42 nTPM
- hippocampal formation: 40 nTPM
- hypothalamus: 40 nTPM
- medulla oblongata: 39 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.02
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to growth factor stimulus
- cellular response to laminar fluid shear stress
- heart development
- insulin-like growth factor receptor signaling pathway
- MAPK cascade
- negative regulation of canonical NF-kappaB signal transduction
- negative regulation of cell migration involved in sprouting angiogenesis
- negative regulation of chemokine (C-X-C motif) ligand 2 production
- negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
- negative regulation of heterotypic cell-cell adhesion
- negative regulation of interleukin-8 production
- negative regulation of response to cytokine stimulus
- negative regulation of smooth muscle cell apoptotic process
- negative regulation of transcription by RNA polymerase II
- positive regulation of cell growth
- positive regulation of epithelial cell proliferation
- positive regulation of protein metabolic process
- positive regulation of transcription by RNA polymerase II
- signal transduction
- ERK5 cascade
Molecular functions
- ATP binding
- MAP kinase kinase activity
- metal ion binding
- protein kinase activity
- protein serine kinase activity
- protein serine/threonine kinase activity
- protein tyrosine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- PB1 domain
- Protein kinase domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Protein kinase, ATP binding site
- Dual specificity MAP kinase kinase
- PB1-like domain
- Protein kinase domain
- PB1 domain
- Dual specificity mitogen-activated protein kinase kinase 5, PB1 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAP2K5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAP2K5 as an antibody target. Whether an autoantibody or antibody against MAP2K5 could matter depends on whether native MAP2K5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAP2K5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAP2K5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...